RBM3 (RNA-binding motif protein 3) is a cold-shock protein that has garnered interest due to its involvement in RNA metabolism, stress response, and potentially tumor biology.
Overall, elevated RBM3 expression tends to correlate with improved prognosis in several cancers, including breast, colorectal, ovarian, and prostate cancers, among others. Its consistent association with better outcomes has highlighted RBM3 as a promising prognostic biomarker.
(Will delete Record if Target field = "Delete") Home